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A Longitudinal Study of
Hospitalization Rates for Patients with
Chronic Disease: Results from the
Medical Outcomes Study
Eugene C. Nelson, Colleen A. McHorney, Willard G. Manning, Jr.,
William H. Rogers, Michael Zubkoff Sheldon Greenfield, John E.
Ware,Jr., and Alvin R. Tarlov
Objective. To prospectively compare inpatient and outpatient utilization rates between prepaid (PPD) and fee-for-service (FFS) insurance coverage for patients with
chronic disease.
Data Source/Study Setting. Data from the Medical Outcomes Study, a longitudinal
observational study of chronic disease patients conducted in Boston, Chicago, and
Los Angeles.
Study Design. A four-year prospective study of resource utilization among 1,681 patients under treatment for hypertension, diabetes, myocardial infarction, or congestive
heart failure in the practices of 367 clinicians.
Data Collection/Extraction Methods. Insurance payment system (PPD or FFS),
hospitalizations, and office visits were obtained from patient reports. Disease and
severity indicators, sociodemographics, and self-reported functional status were used
to adjust for patient mix and to compute expected utilization rates.
Principal Findings. Compared to FFS, PPD patients had 31 percent fewer observed
hospitalizations before adjustment for patient differences (p = .005) and 15 percent
fewer hospitalizations than expected after adjustment (p = .078). The observed rate
of FFS hospitalizations exceeded the expected rate by 9 percent. These results are
not explained by system differences in patient mix or trends in hospital use over
four years. Half of the PPD/FFS difference in hospitalization rate is due to intrinsic
characteristics of the payment system itself.
Conclusions. PPD patients with chronic medical conditions followed prospectively
over four years, after extensive patient-mix adjustment, had 15 percent fewer hospitalizations than their FFS counterparts owing to differences intrinsic to the insurance
reimbursement system.
Key Words. Prepaid health plans, managed care, fee-for-service plans, resource
utilization, system comparisons
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The current interest in promoting prepaid managed care systems and in
extending insurance benefits to people who lack coverage increases the
importance of evaluating healthcare systems based on indicators of value,
that is, the level of quality in relationship to costs (Batalden, Nelson, and
Roberts 1994). Healthcare systems must provide value to all patients, but
particularly to individuals burdened with chronic disease because they stand
to benefit the most from quality care and they consume the most resources.
This study explores the cost side of the value equation. Using longitudinal data from the Medical Outcomes Study (MOS), two major types of costs
were analyzed: utilization of hospitals and physician office visits. Except for a
few small reports on patients with hypertension (Gravdal, Krohm, and Glasser
1991) and cancer (Francis, Polissar, and Lorenz 1984), and Yelin's studies of
patients with rheumatoid arthritis (Yelin, Henke, Kramer, et al. 1985; Yelin,
Shearn, and Epstein 1986; Yelin, Criswell, and Feigenbaum 1996), this is the
first study to assess prepaid versus fee-for-service utilization among patients
with diverse chronic medical diseases. The findings contained in this article go
beyond prior publications on medical care utilization because they are based
on longitudinal data extending over four years (in contrast to cross-sectional
data) (Greenfield, Nelson, Zubkoff, et al. 1992) and they concentrate on older
patients with chronic medical conditions.
Preparation of this article was supported by a grant from the Functional Outcomes Program of
the HenryJ. Kaiser Family Foundation at The Health Institute, New England Medical Center,
Boston, MA (grant number 91-013). The Medical Outcomes Study data collection and analysis
were sponsored by grants from the HenryJ. Kaiser Family Foundation, the Robert WoodJohnson
Foundation, the Pew Charitable Trusts, the Agency for Health Care Policy and Research, the
National Institute on Aging, and the National Institute of Mental Health, and by RAND and the
New England Medical Center from their own research funds.
Address all correspondence and requests for reprints to Eugene C. Nelson, D.Sc., Professor of
Community and Family Medicine and Director, Quality Education, Measurement, and Research,
President's Office, 1 Medical Center Drive, Dartmouth-Hitchcock Medical Center, Lebanon,
NH 03756. Colleen A. McHorney, Ph.D. is a professor in the Departments of Preventive
Medicine and Medicine, University of Wisconsin-Madison Medical School and the William
S. Middleton Memorial Veterans Hospital; Willard G. Manning, Jr., Ph.D. is a professor in
the Institute for Health Services Research, School of Public Health, University of Minnesota;
William H. Rogers, Ph.D. is a senior statistician, the Health Institute, New England Medical
Center; Michael Zubkoff, Ph.D. is a professor and chair of the Department of Community and
Family Medicine, Dartmouth Medical School; Sheldon Greenfield, M.D. is director, Primary
Care Outcomes Research Institute, New England Medical Center; John E. Ware, Jr., Ph.D. is
director, Health Assessment Laboratory, and senior scientist, the Health Institute, New England
Medical Center; and Alvin R Tarlov, M.D. is executive director, the Health Institute, New
England Medical Center. This article submitted to Health Services Research on November 1, 1996,
was revised and accepted for publication onJune 16, 1997.
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Prior research showed that, although patients with prepaid coverage
have fewer hospital stays than comparable fee-for-service patients, they have
as many or more physician visits (Luft 1978; Manning, Leibowitz, Goldberg,
et al. 1984; Miller and Luft 1994; Udvarhelyi et al. 1991). This research
needs to be updated. First, healthcare is changing rapidly in the direction of
more managed care for all types of patients regardless of reimbursement type
(Ellwood and Lundberg 1996). Second, most prior research was conducted
on general populations and spanned only one or two years. It is possible
that prepaid systems conserve resources primarily through savings within the
nonchronic population and that they spend as much or more on patients
with chronic conditions (Dowd,Johnson, and Madison 1986; Experton et al.
1996; Retchin and Brown 1991; Retchin and Preston 1991; Yelin, Criswell,
and Feigenbaum 1996; Yelin, Shearn, and Epstein 1986).
The specific research question addressed is: Do older chronically ill
patients with prepaid insurance have lower inpatient and outpatient utilization
rates than comparable patients with fee-for-service coverage? This article covers only patients whose payment system did not change during the reporting
period. A companion paper explores the impact on utilization of switching
the payment system (Manning, McHorney, Nelson, et al.).

METHODS
As described in detail elsewhere (Greenfield, Rogers, Mangotich, et al. 1995;
Kravitz, Greenfield, Rogers, et al. 1992; Stewart, Greenfield, Hays, et al. 1989;
Stewart and Ware 1992; Tarlov, Ware, Greenfield, et al. 1989; Ware, Bayliss,
Rogers, et al. 1996), the Medical Outcomes Study (MOS) was conducted
during the years 1986 to 1990 in three cities: Boston, Chicago, and Los
Angeles. Each city included a prepaid group practice HMO with at least
100,000 enrollees, numerous multispecialty groups (MSGs) with at least ten
physicians, and solo practitioners having a mixture of fee-for-service and
prepaid insurance arrangements. One prepaid group practice form of HMO
was selected in each city along with 12 MSGs serving the same areas as the
HMOs. From each facility, clinicians between the ages of 31 and 55 were
identified. This analysis excludes mental health providers. Results on the use
of services by depressed patients in the MOS have been reported (Sturm,
Jackson, Meredith, et al. 1995).
We used a three-stage process to sample patients from the practices of
193 general internists, 89 family practitioners, 40 cardiologists, 24 endocrinologists, and 11 nurse practitioners. First, 20,222 patients visiting these clinicians
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were screened, based on doctor reports, for hypertension, diabetes, congestive
heart failure, or a recent myocardial infarction (Kravitz, Greenfield, Rogers,
et al. 1992). This yielded 6,585 patients. Of these, 1,809 were excluded due
to a more serious condition (e.g., surgery, cancer) or lack of authorization for
the study, or because they were not being treated regularly by their MOS
physician for their chronic medical problem (i.e., hypertension, diabetes,
heartfailure, or coronary artery disease [n=871) (Stewart and Ware 1992). The
remaining sample consisted of 4,776 patients seeing 357 clinicians. Of these
4,776 patients, 3,289 accepted enrollment into the study during a second-stage
interview, and we selected 1,741 for study using a random probability sample
that emphasized patients with more serious disease. Of the 1,741 patients,
1,681 contributed utilization data that could be analyzed, and are included in
this report; the 60 patients who failed to provide analyzable utilization data
were excluded from this analysis.
The estimates in this article apply to the original patient population,
people: (1) whose most serious condition is one of the MOS conditions;
(2) were treated in a participating system; and (3) have a regular generalist
or specialist physician. The sample of patients had a substantial number of
Medicare-eligible patients in both the prepaid and fee-for-service systems.
Looking at person years of data (and using the appropriate weights to reflect
initial sampling and sample loss over time), 34 percent of prepaid and 44
percent of fee-for-service patients were 65 years of age or older. Because the
proportions of 65 and older patients are relatively close, it is unlikely that
Medicare eligibility would influence the results that compare utilization for
prepaid versus fee-for-service patients.
MAJOR STUDY VARIABLES
Payment System. This is based on patient reports of major source of payment
in effect at the start of each period of observation (i.e., months 00, 06, 12,
18, 24, and 48). Patients were asked: "Which of the two basic types of health
insurance below best describe the type you rely on most? (a) health insurance
that pays for part or all of each visit to the doctor or hospital stay (For this
type, usually you or the doctor must file an insurance claim.); (b) a prepaid
health plan (usually called an HMO) where you, your employer, or someone
else pays the same amount per month, no matter how many doctor visits or
hospital stays you have (For this type, usually no insurance claim has to be
filed.); or (c) Neither kind-I have no health insurance. Their answers were
used to classify them by type-prepaid (PPD) insurance, fee-for-service (FFS)
insurance, or uninsured-for each observation period. 98 percent of PPD
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and 95 percent of FFS patient reports of payment system agreed with other
verified data sources on the patient's insurance type. Thus, the probable effect
of misclassification (error rates estimated at 2 to 5 percent) would be to reduce
slightly the estimated PPD/FFS differences.
The system of care classification is based only on insurance reimbursement type as reported by the patient; although it would have been desirable
to have, no information was available on the particular features of patients'
individual insurance plans (e.g., presence ofutilization review or use ofsecond
opinions). Consequently, the PPD classification includes large staff/group
model HMOs as well as independent provider group-type arrangements, and
FFS includes large and small group practices and solo practices. Uninsured
patients were excluded from this analysis because there were too few to
provide reliable information; analyses done on this small subgroup suggested
that they had lower hospital stay rates than insured patients.
Utilization Variables. Each patient's utilization was followed over four
years by repeated survey completion. Hospitalization rates were based on
patient reports (at months 00, 12, 24, and 48) of the number of different times
they were in a hospital, nursing home, or convalescent home overnight during
the past 12 months. The number of hospitalizations is based on a 12-month
recall. There are no data for the period after month 36 because study subjects
were not individually interviewed at that point. The measure of physician
office visits was based on patient reports (at months 06, 12, 18, 24, and 48)
of the number of office, clinic, or in-home visits either with a doctor or other
health professional during the past six months, excluding physician visits
during hospitalizations. Patient reports on utilization of hospitals and doctors
reflect overall use of care; they did not distinguish stays or visits for tracer
conditions from stays or visits for other health problems.
We validated those reports using utilization diaries completed by patients. Patient reports of hospitalizations verified 92 percent of hospitalizations. We were unable to estimate "false positive" hospitalization rates. Patient
reports of ambulatory visits were overreported by about 5 percent for the four
months closest to the report, but underreported by about 25 percent in the
two months prior to that. Consequently, visit rates reflect the overall pattern
of outpatient utilization, but not the precise values.
Other Variables. Other measures included age, gender, education, race,
income (based on patient report of annual earnings before deductions and
on patient report of other family income, including interest income, dividend
income, business income, etc.), family size, study site, measures of physical
and mental health status (Ware, Kosinski, Bayliss, et al. 1995), presence or
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absence of the four MOS medical tracer conditions, the severity of these
diseases, a count of comorbid conditions, and time period indicators. The
disease indicators were based on physician reports to standardized questions;
the specific clinical measures used in this report have been documented
in previous MOS publications on patient mix and utilization (Greenfield,
Nelson, Zubkoff, et al. 1992; Kravitz, Greenfield, Rogers, et al. 1992).
DATA ANALYSIS

The analysis had three goals: (1) to compare the characteristics of PPD
and FFS patients (Table 1, further on); (2) to demonstrate the impact of
covariates on utilization (Table 2) to assess selection effects; and (3) to estimate
utilization in the two payment systems, before and after adjusting for observed
differences in patient mix (Table 3).
The unit of analysis was the patient. All significance tests of system
differences (PPD versus FFS) were two-tailed. The observed (unadjusted)
results show actual utilization patterns for patients with chronic medical
conditions distributed naturally between FFS and PPD systems. The expected
(adjusted) results predict utilization patterns if equally sick or healthy patients
were enrolled in each respective system. Observed results reflect the effects of
the payment system, patient mix, and selection factors. These are compared
with expected results, which reflect only patient mix and selection factors.
Size of the payment system effect is the difference between the observed
value and the expected value (bottom panel of Table 3).
The utilization results are based on two comparisons. The observed
(unadjusted) comparisons are based on analysis of variance, where the cluster
effects (i.e., features associated with the sampling method of selecting patients
within the panels of selected physicians in selected practice settings) have been
corrected for, but the patient-mix differences remain. The expected results are
based on multiple regression. For both hospitalizations and visits, utilization
is predicted for each set of patients based on their baseline demographic,
socioeconomic, clinical, and functional health status characteristics. For each
of the utilization rates, we used a two-part model to obtain robust estimates
of the effects of site, demographic, health status, and patient-mix measures
on use (Greenfield, Nelson, Zubkoff, et al. 1992; Duan 1983; Duan et al.
1983; Manning, Duan, and Rogers 1987). The two-part model includes a
logistic regression for reports of any hospitalization or visits and a least squares
regression for the (log) level of use, if any, during that period (e.g., the log of
the number of admissions or visits, if any) (Greenfield, Nelson, Zubkoff, et al.
1992; Manning, Leibowitz, Goldberg, et al. 1984).
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RESULTS
Patient Characteristics
Table 1 displays sociodemographic, health status, and clinical characteristics
of the patients. Compared to FFS, PPD patients were younger (p < .0 1), more
racially diverse (p < .01), more educated (p < .05), and in better physical
health (p < .05). PPD patients were less likely to have congestive heart failure
(p < .01) or a recent MI (p < .01). Severity of illness between PPD and FFS
differed only for MI (PPD less severe, p < .01).

Table 1: Comparison of Prepaid versus Fee-for-Service Patients
at Baseline
Prepaid
(n =771)

Fee-for-Service
(n = 822)

All Patients
(n = 1681)t

50.0
29.2**
31.0
21.7*
2.2
19,990

61.0
45.6
17.2
23.0
15.9
2.1
18,354

59.0
47.7
22.7
21.3
18.3
2.2

19,015

58.8*
65.6

56.5
66.5

57.5
65.8

86.1
14.1
23.2
4.7
2.5**
0.9**
4.8**
1.3

82.9
11.5
28.4
6.4
5.2
2.2
8.0
2.1

83.9
12.9
26.2
5.6
4.1
1.6
7.0
1.7

Sociodemographics
Mean age
% Male
% Nonwhite
% Less than high school
% College
Mean household size
Mean income 1987 ($)

Health Status
Mean physical functioning (0-100 scale)
Mean mental health (0-100 scale)

57.0""

Diagnoses
% Hypertension
% severe
% Diabetes
% severe
% Myocardial infarction
% severe
% Congestive heart failure
% severe

Note: Values shown are based on baseline data collected at the beginning of the study period.
*
Significantly different from FFS atp < .05; ** significantly different from FFS atp < .01.
t Prepaid and fee-for-service subsamples sum to 1,593, not 1,681. This is because (a) information
on payment system was missing at baseline for 63 patients but was available for later observation
periods, and (b) 25 uninsured patients were deleted from the analysis (63 missing baseline
payment data + 25 uninsured + 1,593 prepaid and fee-for-service patients = 1,681).
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Impact ofPatient Characteristics and
Other Design Features on Utilization
Table 2 shows the percentage of variance in hospitalizations and visits explained by different combinations of covariates. These variables were subsequently used in Table 3 to compute expected utilization rates. All of the
variables used in this study (e.g., sociodemographic, functional status, clinical,
and site) explain 7.1 percent of the variance in the number of hospitalizations
and 9.1 percent of the variance in outpatient visits (Table 2, bottom row).
The clinical variables (chronic disease and severity) account for 51 percent of
total explained variance in hospitalization rates (3.6/7.1 = 0.51), whereas the
functional status variables (physical functioning and mental health) account
for 45 percent of total explained variance in visits (4.1/9.1 = 0.45). Sociodemographic, site, and design variables have a modest bearing on hospitalization
but a larger effect on visits (11 percent versus 35 percent of total explained
variance). These results underscore the importance of adjusting for all three
domains of patient mix variables-sociodemographics, clinical variables, and
general health status-in studies of utilization.
Impact ofSystem on Utilization
Inpatient Utilization. As shown in Table 3, the observed percentage (upper
panel) of all PPD patients with any hospitalization averaged 11.4 percent per
year, compared to 14.7 percent of all FFS patients (p = .04). PPD patients
had 31 percent lower hospitalization rates per year than FFS patients (154 for
PPD versus 222 for FFS per 1,000 per year, p = .005). After adjustment
for patient mix (middle panel), the expected percentage of PPD patients
with any hospitalization averaged 12.0 percent per year compared to 13.9
percent for FFS patients. Because PPD patients had less of a disease burden
than FFS patients, the expected PPD hospitalization rates were 15 percent
lower than FFS patients (171 versus 202 hospitalizations per 1,000 per year).
Therefore, the differential between PPD and FFS systems in hospitalizations
reduced by one-half after patient mix variables were taken into account
(31 percent observed versus 15 percent expected differential). Only factors
intrinsic to PPD and/or FFS systems can explain these remaining differences
in hospitalizations. These system effects reduced the PPD hospitalization rate
by -17.4 hospitalizations per 1,000 and increased the FFS rate by +20.4 per
1,000 (p =.078).
Outpatient Visits. The observed percentage of patients having any visit
during a six month time period was 89.8 percent for PPD and 86.0 percent
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Table 2: Percentage of Variance in Hospitalizations and Outpatient
Visits Explained by Covariates
Outpatient
Hospitalizations
Vins
Specification
No Covariates
0 °/
00/
Sociodemographic,* Site,t Designt
0.8%
3.2%
(Change due to clinical variables and functional status)
(6.3°/)
(5.9%)
Sociodemographic, Site, Design, Functional StatusS
3.5%
8.00/o
(Change due to clinical variables)
(3.6°h)
(1.10/0)
Sociodemographic, Site, Design, Clinical Variables**
5.90/
5.0%
(Change due to functional status)
(1.2%)
(4.10/0)
All Covariatestt
7.1%
9.10/
Note: All effects are significant at the 5 percent level except "probability of any visit," which is
due to the small number of patients with zero use of services.
* Sociodemographic variables used as covariates were age, gender, education, race, income,
family size.
t Site variables used as covariates were the study sites that refer to one of three cities: Boston,
Chicago, or Los Angeles.
1 Design variables used as covariates are associated with clustering effects (i.e., the effects
associated with the MOS sampling design, which selected "clusters" of active patients from
the panels of patients cared for by selected physicians practicing in selected delivery systems).
§ Functional status variables used as covariates include two measures of general health status:
physical functioning and mental health.
** Clinical variables used as covariates include the presence or absence of the four MOS medical
tracer conditions, the severity of these diseases, and comorbidity.
tt Proportion of variance explained in utilization measures by all covariates listed (i.e., the rsquare values for stays and visits, respectively, are 0.071 and 0.091).

for FFS (p = .061). The expected proportions for any visits were 87.4 percent
for PPD versus 88.0 percent for FFS. Consequently, the effect of payment
system on the percentage of patients having any visit is to boost the rate by
+2.4 percent among PPD patients and to reduce the rate by -2.0 percent
for FFS; although the percentage difference is not very large, it is statistically
significant (p = .015).
The observed number of visits per patient for PPD was slightly, but
not significantly, higher than FFS (4.55 PPD versus 4.30 FFS visits per six
months, p = .407); the expected visit rates were virtually identical (4.36 PPD
versus 4.38 FFS). Therefore, the effect of payment system on the number of
visits per six months is very small and not statistically significant (i.e., +0.19
PPD versus -0.08 FFS visits per six months, p = .314).
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Table 3: Comparison of Observed and Expected Utilization Rates
for Prepaid versus Fee-for-Service Systems
Prepaid Fee-for-Service Difference
Panel 1: Observed Utilization Rates
Hospitalizations
Any hospitalizations (%)

11.4

14.7

-3.3

(.042)*
Number of hospitalizations per 1,000 patients per year

154

222

-68.0

(.005)
Visits
Any outpatient visits (/)

89.8

86.0

3.8

(.061)
Number of outpatient visits per patient per 6 months

4.55

4.30

.25

(.407)
Panel 2: Expected Utilization Rates
Hospitalizations
Any hospitalizations (%)
Number of hospitalizations per 1,000 patients per year
Visits
Any outpatient visits (%)
Number of outpatient visits per patient per 6 months

12.0
171

13.9
202

NA
NA

87.4
4.36

88.0
4.38

NA
NA

Panel 3: System Effect (Observed-Expected)
Hospitalizations
Any hospitalizations (%)

-0.7

0.8

-1.5

(.321)
Number of hospitalizations per 1,000 patients per year

-17.4

20.4

-37.8

(.078)
Visits

Any outpatient visits (/)

2.4

-2.0

4.4

(.015)
Number of outpatient visits per patient per 6 months

0.19

-0.08

0.27

(.314)
* Numbers in parentheses show the p-value for the comparison between FFS and PPD payment
systems.

Test for Interactions and Time Trends. The effect payment system has on
utilization might differ depending on patient characteristics. For example,
patients of lower socioeconomic status may be less effective in slipping
through gatekeeping passages of prepaid care than their more advantaged
counterparts. Also, PPD care may accrue its cost edge among healthier
patients but expend equivalent resources on their sicker patients.
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To test these hypotheses, we split our sample of PPD and FFS patients
into thirds based on their physical functioning or income. Contrary to the
hypothesis, FFS and PPD hospitalization rates were most different at the
sickest end of the patient population. Sicker PPD patients had 12 percent
fewer hospitalizations than FFS (p = .04), whereas at the well end of physical
functioning, PPD had 4 percent more hospitalizations than FFS (p = .08).
The same general pattern was observed after adjusting for sociodemographic,
health status, and clinical variables using the two-part model. A similar
analysis by thirds of the income distribution produced insignificant results
and no apparent pattern.
It might also be hypothesized that secular trends toward utilization
management of hospital care might have caused the PPD versus FFS hospitalization rates to converge between 1986 and 1990. A comparable analysis
on hospitalization rates over time generally showed that the unadjusted rates
were trending down in both systems.

DISCUSSION
This study is distinct from others on comparative utlization rates because the
patients are older (mean age of 60), have chronic disease, and were followed
prospectively over four years. Prepaid systems of care, after adjusting for all
relevant characteristics (including demographic, social, and health variables),
hospitalized their patients with chronic medical disease 15 percent less often
than fee-for-service systems from 1986 to 1990. Half of this reduction was
due to the effect of the insurance payment system itself. This study could
not discern the specific elements of prepaid systems (rigorous precertification
requirements, utilization inhibitors, physician specialty, physician incentive,
and others) responsible for the reduction.
Limitations of the Study
These findings have several limitations. First, the data were collected several
years ago during the 1986 to 1990 time period. Many changes have taken
place in the healthcare marketplace and regional delivery system since that
time. Prepaid plans are becoming more prevalent, more aggressive, and more
diverse. Traditional fee-for-service plans (that have no utilization review and
other methods to limit utlization) are increasingly rare and in some areas of
the country are virtually extinct. Thus, the first limitation is the age of the data
and the relevancy to today's world.
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Second, because the study was conducted in three different communities
and involved patients with scores of different insurance plans which themselves were evolving over time, it was not possible to gather accurate data on
the specific features of the different plans that would have been responsible
for different patterns of utilization. It is not possible to say precisely what
the specific features were of the insurance coverages that we referred to
collectively as "fee-for-service" or "prepaid." Thus, the characteristics of the
causal system (fee-for-service versus prepaid care) that accounted for observed
differences could not be identified.
Third, although a small minority, the uninsured are a very important
subpopulation with special health needs that may not be met. Because there
were so few uninsured in the MOS sample, this important group had to
be excluded from the analysis. However, the limited analyses which were
conducted on this subpopulation suggested that they were less likely to use
patient services than their prepaid or fee-for-service counterparts.
Fourth, because of their greater burden of illness, the patients in this
study have higher than average utilization rates. For example, the study
population averaged about nine outpatient visits per year, while the general
population averaged about five visits (Benson and Marano 1994). Furthermore, several design features of the MOS may limit generalizability: (1) the
study was conducted only in large urban communities; (2) just three HMOs
and a limited number of large multispecialty group practices were included;
(3) patients were entered into the longitudinal panel only if under treatment
in the private sector of medicine; and (4) data were not collected on either
the duration or the costs of hospitalizations.
Even after allowing for all of these important limitations, we believe that
the substantive results are essentially correct and can be used for purposes
of systems improvement and policy discussions. In addition, we believe this
study merits attention because of its special focus and its research methods.
The focus was on older people afflicted by common chronic medical problems
who can benefit from good care or can be harmed by its lack (Ware, Bayliss,
Rogers, et al. 1996). The research methods involved prospective, longitudinal
observation of patients in real world delivery systems using a balanced set of
outcome measures (clinical outcomes, functional outcomes, satisfaction with
care, health risk status) and resource intensity indicators (hospitalization rates,
office visit rates) to evaluate issues related to quality and costs of care.
Contrast with Prior Research
Although exceptions can be found, the weight of the evidence accumulated
from prior research, and this specific study, suggests that prepaid patients
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tend to be healthier, have a smaller burden of disease, use less inpatient care,
have shorter lengths of stay once admitted, and have similar or somewhat
higher rates of physician visits than their fee-for-service counterparts (Dowd,
Johnson, and Madison 1986; Francis, Polissar, and Lorenz 1984; Gravdal,
Krohm, and Glasser 1991; Luft 1978; Manning, Leibowitz, Goldberg, et al.
1984; Miller and Luft 1994; Stern et al. 1989; Yelin, Henke, Kramer, et al.
1985; Yelin, Shearn, and Epstein 1986). Two recent studies examined utilization patterns across prepaid and fee-for-service systems of care. In the first,
Medicare HMO patients, compared to their Medicare FFS counterparts, had
greater expenditures for outpatient physician services and lower expenditures
for home healthcare, but equivalent inpatient expenditures (Experton et al.
1996). In the second study, there were no differences in resource utilization by
PPD versus FFS care for patients with rheumatoid arthritis (Yelin, Criswell,
and Feigenbaum 1996). Variation in results among and between these recent
studies may be attributed to differences in study methodology (e.g., casemix adjustment, unmeasured health status differences between systems, and
intention-to-treat analysis), differences in the mix of patients and providers
sampled and studied and, most importantly, noteworthy changes in the configuration of FFS and PPD healthcare systems during the natural history in
which these studies were conducted. Nonetheless, the results reported here
extend our knowledge of system differences to older people with multiple
chronic conditions, who are most likely to be high users of care.

Policy Implications and Final Comment
There is some opinion that spending 14 percent of our economic output
on health services is excessive. Achievement of a 15 percent reduction in
hospitalization rate for patients with chronic disease, therefore, is a significant
accomplishment that should be retained in the system. The impact of the 15
percent reduction must not be diluted by lengthier hospitalizations, greater
use of high-cost inpatient tests and procedures, or high rates of costly disenrollments. Similarly, the potential cost savings must not be counterweighted by
declines in the quality of the doctor-patient relationship, diminished patient
satisfaction with services, or by less favorable disease- or health-related quality
of life outcomes. Data monitoring systems must be incorporated into the
system's routine in order to provide an empirical basis for quality upgrade, so
that the advantage of reduced hospitalization rates yield an overall advantage
to patients' well-being.
This research found that prepaid patients with chronic medical conditions have fewer hospitalizations than their fee-for-service counterparts after
adjustment for sociodemographic, functional status, and clinical variables.
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The implications of these findings (which promise lower costs for prepaid
patients) must be balanced with other aspects of value, including clinical
outcomes, symptom status, general health status, and satisfaction with care
(Clement et al. 1994; Rubin, Gandek, Rogers, et al. 1993; Greenfield, Rogers,
Mangotich, et al. 1995; Ware, Bayliss, Rogers, et al. 1996).
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